SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-301991
Filing Date
2012-07-13
Accepted
2012-07-13 15:03:55
Documents
4
Period of Report
2012-07-09
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d378381d8k.htm 8-K 33684
2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH LOUIS FERRARI d378381dex101.htm EX-10.1 139048
3 PRESS RELEASE d378381dex991.htm EX-99.1 14887
4 GRAPHIC g378381ex991.jpg GRAPHIC 7003
  Complete submission text file 0001193125-12-301991.txt   198797
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

IRS No.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15313 | Film No.: 12961707
SIC: 2833 Medicinal Chemicals & Botanical Products